- Fenofibric acid: in combination therapy in the treatment of mixed dyslipidemia - (https://pubmed.ncbi.nlm.nih.gov/19929038/)
- Fenofibric acid for hyperlipidemia - (https://pubmed.ncbi.nlm.nih.gov/22404421/)
- Fenofibrate - (https://medlineplus.gov/druginfo/meds/a601052.html )
- Fenofibrate - (https://www.ncbi.nlm.nih.gov/books/NBK559219/ )
Fenofibric Acid (Finate (200 mg)) is used to reduce the cholesterol in patients with obesity problem. It is a HMG-CoA reductase inhibitor (statin). It slows the production of cholesterol in the body.
The information provided on this page is intended to serve as a comprehensive resource and should not be a substitute to professional medical advice. If you have concerns it is always best to speak with a healthcare professional.
Finate (200 mg) - Franco-Indian Pharmaceuticals Pvt. Ltd.
Finate (200 mg) Capsule
Generic : Fenofibric Acid
₹
84.11
200mg
10 Capsules
Substitute/Alternative Medication to Finate (200 mg)
Fenacor (200 mg) | Fenacor FC (160 mg) | Feno TG (160 mg) | Fenobate (160 mg) | Fenobate (200 mg) | Fenobate (67 mg) | Fenocor (200 mg) | Fenocor (67 mg) | Fenofibric (105mg) | Fenofibric (35mg)
When is Finate (200 mg) prescribed?
It is prescribed for -
⇨
Obesity
